Amlodipine: Difference between revisions
(correciton) |
(updated reactions) |
||
| Line 32: | Line 32: | ||
==Adverse Reactions== | ==Adverse Reactions== | ||
===Serious=== | ===Serious=== | ||
*Angina, MI, Hypotension, Hepatitis, Erythema multiforme | |||
===Common=== | ===Common=== | ||
*Peripheral edema, fatigue, palpitations, dizziness, nausea, flushing, eczematous eruptions | |||
==Pharmacology== | ==Pharmacology== | ||
Revision as of 02:50, 23 February 2015
General
- Type: Anti-Hypoertensive (dihydropyridine-CCB)
- Dosage Forms: 2.5, 5, 10mg
- Common Trade Names: Norvasc
Adult Dosing
- HTN
- 5-10mg PO qDaily
- Start: 5mg PO qDaily for intial antihypertesnive, do 2.5 if elderly or 2nd line drug
Pediatric Dosing
- HTN
- 2.5-5mg PO qDaily
Special Populations
- Pregnancy Rating: C
- Lactation: Safety Unknown
- Renal Dosing
- Adult: no adjustment
- Pediatric: no adjustment
- Hepatic Dosing
- Adult: Start at 2.5mg qDaily
- Pediatric: not defined
Contraindications
- Allergy to class/drug
- Severe CAD, AS, CHF
- Re-dose/Caution: Elderly/Hepatic Impairment
Adverse Reactions
Serious
- Angina, MI, Hypotension, Hepatitis, Erythema multiforme
Common
- Peripheral edema, fatigue, palpitations, dizziness, nausea, flushing, eczematous eruptions
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action: